Clinical Trials Browser

Phase 2/3 × Leukemia × Rituximab × Clear all

NCT01046825 2025-12-10

Mature B-Cell Lymphoma And Leukemia Study III

Phase 2/3 Active not recruiting

128 enrolled 12 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin